Amit Lahoti, M.D.
Department of Emergency Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Internal Medicine, Baylor College of Medicine, Houston, TX
Education & Training
Degree-Granting Education
| 1998 | University of Texas Medical School at San Antonio, San Antonio, TX, USA, MD, Doctor of Medicine |
| 1994 | University of Texas at Austin, Austin, TX, USA, BA, Biology |
Postgraduate Training
| 2004-2006 | Clinical Fellowship, Nephrology, University of Texas Medical School at Houston, Houston, TX |
| 2002-2004 | Hospitalist, Hospitalist, Kelsey-Seybold Clinic, Houston, TX |
| 2001-2002 | General Internist, Macgregor Medical Association, Houston, TX |
| 1998-2001 | Clinical Residency, Internal Medicine, University of Texas Medical School at Houston, Houston, TX |
Board Certifications
| 2006 | American Board of Internal Medicine-Nephrology |
| 2002 | American Board of Internal Medicine-Internal Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Department of Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Administrative Appointments/Responsibilities
Education Director (Division level), The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2021
Baylor College of Medicine Nephrology Fellowship Rotation Site Director, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2021
Baylor College of Medicine Internal Medicine Residency Rotation Site Director, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2023
Onconephrology Fellowship Associate Program Director, Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
UT Health Nephrology Fellowship Rotation Site Director, Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2021
Section Chief of Nephrology ad interim, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2013
Institutional Committee Activities
Chair, GME Institutional Review Subcommittee, 2019 - Present
Voting Member, Graduate Medical Education Committee, 2012 - Present
Member, Pharmacy and Therapeutics Committee, 2008 - 2015
Member, Clinical Research Committee, 2008 - 2011
Member, Diabetes Workgroup Committee, 2006 - 2007
Honors & Awards
| 2020 | Baylor House Staff Teaching Faculty Award, Baylor College of Medicine Department of Internal Medicine |
| 2019 | President's Recognition for Faculty Excellence, UT MD Anderson Cancer Center |
| 2018 | Faculty Excellence Award in Education Nominee, UT MD Anderson Cancer Center |
| 2017 | President's Recognition for Faculty Excellence, UT MD Anderson Cancer Center |
| 2016 | Baylor House Staff Teaching Faculty Award, Baylor College of Medicine Department of Internal Medicine |
| 2014 | Clinician Leader of the Year, Division of Internal Medicine |
| 2013 | Faculty Scholar Award (3-year award), UT MD Anderson Cancer Center |
| 2010 | Cyrus Scholar Award Semi-Finalist, UT MDACC, The Division of Internal Medicine Research Retreat |
| 2008 | Cyrus Scholar Award Finalist, UT MDACC, The Division of Internal Medicine Research Retreat |
| 2008 | Research Citation Finalist, Society of Critical Care Medicine 37th Critical Care Congress |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immunother Cancer 7(1):2, 2019. e-Pub 2019. PMID: 30612580.
- Aria AB, Chen L, Glass WF, Lahoti A, Chon SY. Leukocytoclastic vasculitis with late-onset Henoch-Schönlein purpura after trifluridine/tipiracil treatment. Dermatol Online J 24(10), 2018. e-Pub 2018. PMID: 30677817.
- Lahoti A, Glass WF. Multiple myeloma and kidney disease. Journal of Onco-nephrology 1(2):95-102, 2017.
- Doshi M, Lahoti A, Danesh FR, Batuman V, Sanders PW, American Society of Nephrology Onco-Nephrology Forum. Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?. Clin J Am Soc Nephrol 11(12):2288-2294, 2016. e-Pub 2016. PMID: 27526707.
- Saunders IM, Lahoti A, Chemaly RF, Trevino C, Westmoreland M, Hosing C. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. J Oncol Pharm Pract 22(2):325-31, 2016. e-Pub 2014. PMID: 25488905.
- Sasaki K, Lahoti A, Jabbour E, Jain P, Pierce S, Borthakur G, Daver N, Kadia T, Pemmaraju N, Ferrajoli A, O'Brien S, Kantarjian H, Cortes J. Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients with Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-existing Liver and/or Renal Dysfunction. Clin Lymphoma Myeloma Leuk 16(3):152-62, 2016. e-Pub 2015. PMID: 26796981.
- Yilmaz M, Lahoti A, O'Brien S, Nogueras-González GM, Burger J, Ferrajoli A, Borthakur G, Ravandi F, Pierce S, Jabbour E, Kantarjian H, Cortes JE. Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Cancer 121(21):3894-904, 2015. e-Pub 2015. PMID: 26217876.
- Abudayyeh AA, Lahoti A, Salahudeen AK. Onconephrology: the need and the emergence of a subspecialty in nephrology. Kidney Int 85(5):1002-4, 2014. PMID: 24786870.
- Salahudeen AK, Ali N, George M, Lahoti A, Palla S. Tolvaptan in hospitalized cancer patients with hyponatremia: A double-blind, randomized, placebo-controlled clinical trial on efficacy and safety. Cancer 120(5):744-51, 2014. e-Pub 2013. PMID: 24895288.
- Salahudeen AK, Doshi SM, Pawar T, Nowshad G, Lahoti A, Shah P. Incidence Rate, Clinical Correlates, and Outcomes of AKI in Patients Admitted to a Comprehensive Cancer Center. Clin J Am Soc Nephrol 8(3):347-54, 2013. e-Pub 2012. PMID: 23243268.
- Smith J, Murthy R, Lahoti A, Odisio B, Avritscher R, Chasen B, Mahvash A. Temporary Balloon Occlusion of the Common Hepatic Artery for Yttrium-90 Glass Microspheres Administration in a Patient with Hepatocellular Cancer and Renal Insufficiency. Case Rep Radiol 2013:560758, 2013. e-Pub 2013. PMID: 23710405.
- Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia in Hospitalized Cancer Patients and its Impact on Clinical Outcomes. Am J Kidney Dis 59(2):222-8, 2012. e-Pub 2011. PMID: 22001181.
- Raval M, Gulbis A, Bollard C, Leen A, Chemaly R, Shpall E, Lahoti A, Kebriaei P. Evaluation and Management of BK Virus-Associated Nephropathy Following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 17(11):1589-93, 2011. e-Pub 2011. PMID: 21767514.
- Lahoti A, Nates JL, Wakefield CD, Price KJ, Salahudeen AK. Costs and outcomes of acute kidney injury in critically ill patients with cancer. J Support Oncol 9(4):149-55, 2011. PMID: 21809520.
- Lahoti A, Kantarjian H, Salahudeen AK, Ravandi F, Cortes JE, Faderl S, O'Brien S, Wierda W, Mattiuzzi GN. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer 116(17):4063-8, 2010. PMID: 20564156.
- Salahudeen AK, Kumar V, Madan N, Xiao L, Lahoti A, Samuels J, Nates J, Price K. Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol (8):1338-46(8):1338-46, 2009. e-Pub 2009. PMID: 19628685.
- Parikh GC, Amjad AI, Saliba RM, Kazmi SM, Khan ZU, Lahoti A, Hosing C, Mendoza F, Qureshi SR, Weber DM, Wang M, Popat U, Alousi AM, Champlin RE, Giralt SA, Qazilbash MH. Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma. Biol Blood Marrow Transplant (7):812-6(7):812-6, 2009. PMID: 19539212.
Manuals, Teaching Aids, Other Teaching Publications
- Lahoti A, Humphreys B. AKI Associated with Malignancies. American Society of Nephrology Online Curricula: Onco-Nephrology.
- Lahoti A. Section of Nephrology Fellows Syllabus. MD Anderson Cancer Center, Section of Nephrology: Houston, 2006.
- Lahoti A. Chronic Kidney Disease: Questions and Answers. Patient Education Online: Houston, Texas, 2006.
- Lahoti A. Acute Renal Failure: Questions and Answers. Patient Education Online: Houston, Texas, 2006.
Abstracts
- Mauiyyedi S, Lahoti A, Tchakarov A. Glomerular Intracytoplasmic Vacuolization in a Patient Receiving Polyethylene Glycol Biopharmaceutical. Journal of the American Society of Nephrology 35(Abstract Issue):754, 2024.
- Ratnani P, Mamlouk O, Lahoti, A, Al Shaarani M. Paraneoplastic Membranoproliferative Glomerulonephritis Associated with Neoplasm Transformation. Journal of the American Society of Nephrology 34(Abstract Issue):789, 2023.
- Shang H, Mamlouk O, Bhattarai M, Lahoti A, Workeneh B, Glass W. Myeloma-Like Cast Nephropathy in a Patient with Pancreatic Mixed Acinar- Neuroendocrine Cancer. Journal of the American Society of Nephrology 29(Abstract Issue):793, 2018.
- Abudayyeh A, Kalu C, Lakhani L, Workeneh B, Lahoti A, Chen S, Danesh F, Abdelrahim M. Incidence of AKI in a Large Retrospective Cancer Cohort Using Checkpoint Inhibitors. Journal of the American Society of Nephrology 29:1039, 2018.
- Ziaolhagh A, Ogbonnaya-Odor C, Teakell J, Lahoti A. Recurrent SIADH: A Rare Complication of Intrathecal Interleukin-2 Treatment for Melanoma with Brain Metastases. Journal of the American Society of Nephrology 28(Abstract Issue):395, 2017.
- Selamet U, Ziaolhagh A, Makhani L, Lahoti A, Workeneh B, Tchakarov A, Glass W, Abudayyeh A. Nephrotoxicity of Immune Checkpoint Inhibitors: MD Anderson Cancer Center’s Experience. Journal of the American Society of Nephrology 28(Abstract Issue):404, 2017.
- Kala J, Lahoti A. Hyponatremia Is Common among Patients Receiving Stem Cell Transplant and Is an Independent Predictor of Mortality. Journal of the American Society of Nephrology 27(Abstract Issue):205A, 2016.
- Kala J, Lahoti A, Abudayyeh A. Rare Cause of Granulomatous Acute Interstitial Nephritis. Journal of the American Society of Nephrology 27(Abstract Issue):381A, 2016. e-Pub 2016.
- Kala J, Lahoti A. Anti-Thymocyte Globulin Induced Non Cardiogenic Pulmonary Edema. Journal of the American Society of Nephrology 26(Abstract Issue):983A, 2015.
- Ali N, Palla S, George M, Lahoti A, Salahudeen A. Randomized, Double-Blind, Placebo-Controlled Trial of Tolvaptan in Cancer Patients with Hyponatremia: Preliminary Report. Journal of the American Society of Nephrology 23(Abstract Issue):994A, 2012.
- Thomas E, Doshi S, Lahoti A, Salahudeen A. The Cost and Clinical Outcomes of Hypernatremia in Hospitalized Cancer Patients. Journal of the American Society of Nephrology 22(Abstract Issue):518A, 2011.
- Lahoti A, Salahudeen AK. Predictors, Costs, and Outcomes of Acute Kidney Injury in Critically Ill Patients with Cancer. Journal of the American Society of Nephrology 21(Abstract Issue):124A, 2010.
- Salahudeen AK, Lahoti A. Acute Kidney Injury in Cancer Patients: Incidence, Risk Factors, and Outcomes. Journal of the American Society of Nephrology 21(Abstract Issue):124A, 2010.
- Lahoti A, Salahudeen AK. Acute Kidney Injury Occurs in a Significant Number of Patients Undergoing Stem Cell Transplant and is Associated with Decreased Survival. Journal of the American Society of Nephrology 21(Abstract Issue):124A, 2010.
- Lahoti A, Salahudeen AK. Acute Kidney Injury as Defined by the RIFLE Classification Had Prognostic Utility in Critically Ill Patients with Cancer. Critical Care Medicine 35(12 Suppl):A240, 2007.
- Lahoti A, Nates J, Samuels J, Wakefield CD, Price KJ, Salahudeen AK. RIFLE Criteria for Acute Kidney Injury Correlates with Hospital Mortality in Critically Ill Patients with Cancer. Journal of the American Society of Nephrology 18(Abstract Issue):959A, 2007.
- Madan N, Kumar V, Lahoti A, Nates J, Price K, Salahudeen AK. Renal Replacement Therapy in Critically Ill Cancer Patients Using Continuous Sustained Low Efficiency Dialysis (C-SLED): Feasibility, Efficacy and Tolerability. Journal of the American Society of Nephrology 18(Abstract Issue):450A, 2007.
Book Chapters
- Lahoti A. Renal Emergencies in Patients with Cancer. In: Oncologic Emergency Medicine: Principles and Practice. 2nd. Springer Nature, 2020.
- Lahoti A, Danesh F. Nephro-Urologic Emergencies in Patients With Cancer. In: Oncologic Emergency Medicine: Principles and Practice. 1st. Springer: Switzerland, 273-284, 2016.
- Lahoti A, Cruz-Carreras MT, Salahudeen AK. Nephro-urological Emergencies in Patients with Cancer. In: Oncologic Emergencies. 1st. Springer Verlag: New York, 143-160, 2016.
- Sachdeva M, Lahoti A, Mathew A. Chronic Kidney Disease in Cancer Patients. In: Onco-Nephrology: Cancer, Chemotherapy and the Kidney. 1st. Springer, 2015.
- Lahoti A. Multiple Myeloma and Kidney Disease. In: Renal Disease in Cancer Patients. 1st. Academic Press, 2013.
- Busaidy NL, Lahoti A, Hanley DA. Secondary Hyperparathyroidism. In: Handbook of Parathyroid Diseases: A Case-Based Practical Guide. Springer, 141-158, 2012.
- Finkel KW, Lahoti A, Foringer JR. Renal Disease in Cancer Patients. In: Brenner and Rector's The Kidney. 9th. Saunders, 1536-1554, 2012.
Patient Reviews
CV information above last modified October 22, 2024